Stanley M. Marks

Terminal Transferase as a Predictor of Initial Responsiveness to Vincristine and Prednisone in Blastic Chronic Myelogenous Leukemia

Stanley M. Marks, David Baltimore, Ronald P. McCaffrey · New England Journal of Medicine · 1978 · 225 citations

Medicine, Hematology, Oncology +12

Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Kenneth A. Foon, Michael Boyiadzis, Stephanie R. Land et al. · Journal of Clinical Oncology · 2008 · 176 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)

Ghady Haidar, Mounzer Agha, Andrew Bilderback et al. · Clinical Infectious Diseases · 2022 · 115 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T‐cell lymphoma, nasal type, in the United States

John A. Vargo, Arisha Patel, Scott Glaser et al. · Cancer · 2017 · 71 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis

Chaoyuan Kuang, Yongseok Park, Ryan C. Augustin et al. · Clinical Epigenetics · 2022 · 71 citations · Full text

Medicine, Oncology, Pharmacology +14